Ultrasound in Patients With Atypical Shape of PsoriasisECHOPSONCT02899429
Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis
An observational study of Ultrasound in Patients With Atypical Shape of Psoriasis, run by University Hospital, Brest at 1 site in France.
Trial summary
Systematic study of the ultrasound infringements of tendons chest expanders of entheses the most involved in spondylarthropathies and small joints of hands and feet in expanding patients of psoriasis to estimate if there is an infra-clinical infringement of the psoriasic rheumatism . Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Ultrasound in Patients With Atypical Shape of Psoriasis
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- Dec 2014to Dec 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Major patient with atypical cutaneous psoriasis consultant at University Hospital of Brest
Who may be able to join
- Patients over 18 years
- Atypical psoriasis of the scalp and / or nails and / or psoriasis of folds
- Patient agreeing to participate in the study
Who cannot join
- Psoriatic arthritis
- Rheumatic pain
- Arthritis
- Joint Trauma in hands, elbows knees, feet
- Current treatment with methotrexate, soriatane, cyclosporine, corticosteroids
- Current treatment with biological therapy (anti-TNF, anti IL 12-23)
- Previous history of rheumatic disease: inflammatory, microcrystalline, osteoarthritis
- Patients in physical or mental incapacity to agree
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Systematic Descriptive Experimental Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients Presenting an Atypical Form of Psoriasis
Systematic study of the ultrasound infringements of tendons chest expanders of entheses the most involved in spondylarthropathies and small joints of hands and feet in expanding patients of psoriasis to estimate if there is an infra-clinical infringement of the psoriasic rheumatism .
What is being measured
The primary outcome is the main question the study is designed to answer.
Infra clinical infringements of the entheses
Measurement of the thickness in millimeters (mm) in anteroposterior diameter of each entheses (quadricipatal tendon, calcaneal tendon and plantar aponeurosis)
Measured: 1 year
Infra clinical infringements of the nails
Measurement mm of the nail plate and matrix of the nail. It will be evaluate by using power Doppler the vascularisation in 3 grades of the nail ( grade 0=normal, grade 1=moderate vascularisation , grade 3:= abnormal vascularisation)
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2016 (estimated)
- Study startDec 2014
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ultrasound in Patients With Atypical Shape of PsoriasisStudies of the same condition, open and under way.
- More trials run by University Hospital, BrestThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Brest
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sandrine Jousse, Study director, CHRU de Brest
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02899429
- Sponsor's protocol ID
- ECHOPSO (RB14.120)
- Acronym
- ECHOPSO
- Status last verified
- Sep 2016
- First submitted
- 30 Aug 2016
- Last updated
- 14 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Systematic Descriptive Experimental Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients Presenting an Atypical Form of Psoriasis
- ClinicalTrials.gov ID
- NCT02899429
- Acronym / sponsor ID
- ECHOPSO / ECHOPSO (RB14.120)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- University Hospital, BrestUniversity, hospital or other
- Study start
- Dec 2014
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 14 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Systematic study of the ultrasound infringements of tendons chest expanders of entheses the most involved in spondylarthropathies and small joints of hands and feet in expanding patients of psoriasis to estimate if there is an infra-clinical infringement of the psoriasic rheumatism .
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Major patient with atypical cutaneous psoriasis consultant at University Hospital of Brest
Key inclusion criteria (3 listed)
- Patients over 18 years
- Atypical psoriasis of the scalp and / or nails and / or psoriasis of folds
- Patient agreeing to participate in the study
Key exclusion criteria (8 listed)
- Psoriatic arthritis
- Rheumatic pain
- Arthritis
- Joint Trauma in hands, elbows knees, feet
- Current treatment with methotrexate, soriatane, cyclosporine, corticosteroids
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Infra clinical infringements of the entheses
Time frame: 1 year
Measurement of the thickness in millimeters (mm) in anteroposterior diameter of each entheses (quadricipatal tendon, calcaneal tendon and plantar aponeurosis)
Infra clinical infringements of the nails
Time frame: 1 year
Measurement mm of the nail plate and matrix of the nail. It will be evaluate by using power Doppler the vascularisation in 3 grades of the nail ( grade 0=normal, grade 1=moderate vascularisation , grade 3:= abnormal vascularisation)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2016.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sandrine Jousse study director
CHRU de Brest
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Ultrasound in Patients With Atypical Shape of Psoriasis, run by University Hospital, Brest at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Infra clinical infringements of the entheses (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2016; AzTrials last refreshed its copy on 8 Nov 2026.